Document Security Systems Inc (AMEX: DMC | news | PowerRating | PR Charts ) develops optical security technologies worldwide. It licenses its technology and sells products that use its optical anti-scanning, anti-counterfeiting technologies. The company offers anti-counterfeiting products and technologies, such as AuthentiGuard On-Demand, which provides the ability to produce secure documents; AuthentiGuard Laser Moire that identifies counterfeit reproductions for photographs, portraits, currency, driver's licenses, postage stamps, tickets, labels, brand packaging, or documents; AuthentiGuard Prism, which embeds hidden words, images, or logos; and AuthentiGuard Pantograph 4000 that produces clear and readable warning words used for gift certificates, school transcripts, coupons, tickets, checks, packing slips, receipts, schematic drawings, plans, music, scripts, training manuals, business plans, internal memos, letterhead, legal forms, and prescription pads. It also provides AuthentiGuard Survivor 21, which protects printed checks from duplication; AuthentiGuard Obscurascan that protects against the counterfeiting of process color document, package, image, or label; AuthentiGuard Block-Out, which makes it difficult to reproduce protected documents on digital color copiers; AuthentiGuard MicroPerf, an optical variable technology that creates a verifier mark; AuthentiGuard Phantom, which uses hidden images or words that can be viewed without special equipment; and AuthentiGuard VeriGlow, a customized document security system that utilizes photosensitive inks and incorporates embedded hidden messages or images. In addition, the company owns and operates Legalstore.com, which sells legal supplies and documents, such as security paper and products. Its customers include governments, law enforcement agencies, security printers, check and forms printers, and corporations. The company, formerly known as New Sky Communications, Inc., was founded in 1984 and is based in Rochester, New York. With 13.68 million shares outstanding and 1.55 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of DMC. According to quarterly data provided by the SEC, there were still 10,359 shares of DMC that were failing-to-deliver as of September 27, 2007.
Answers Corp. (NASDAQ: ANSW | news | PowerRating | PR Charts ) owns and operates Answers.com, which is an Internet information portal. The company, through its Web site, www.answers.com, provides users with answer-based search services covering various topics, such as arts and literature, biographies, business, entertainment, food and drink, general encyclopedias, health and wellness, history, law, reference, science and technology, and travel and leisure. It also operates wikianswers.com, which is a Q&A platform where users ask various questions and a community of people answers them. In addition, the company offers 1-Click Answers, which is a software application tool that facilitates access to Answers.com. 1-Click Answers allows users working in various applications, such as e-mail, spreadsheet, word processing, and database to click on a word or phrase within a document and access Answers.com's online library that provides information in a pop-up window. The company was founded in 1998. It was formerly known as GuruNet Corporation and changed its name to Answers Corporation in 2005. Answers Corporation is headquartered in Jerusalem, Israel. With 7.85 million shares outstanding and 774,400 shares declared short as of March 2008, there is no longer a failure to deliver in shares of ANSW. According to quarterly data provided by the SEC, there were still 40,014 shares of ANSW that were failing-to-deliver as of September 28, 2007.
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX | news | PowerRating | PR Charts ) engages in the design, optimization, and development of novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to use structure-based drug design to discover and develop small molecule pharmaceuticals. Its lead product candidate, Fodosine, is a transition-state analog inhibitor of the target enzyme purine nucleoside phosphorylase (PNP). This product is in Phase IIa trial for patients with T-cell leukemia and a combination IV, and a Phase I pharmacokinetic trial in healthy volunteers. Additionally, Fodosine is in a Phase I trial with an oral formulation in cutaneous T-cell lymphoma, a Phase II trial in chronic lymphocytic leukemia, and a Phase I/II trial in B-cell acute lymphoblastic leukemia. The company's pipeline products include PNP Inhibitor (BCX-4208), Hepatitis C Polymerase Inhibitors, Neuraminidase Inhibitor (peramivir), and Tissue Factor/Factor VIIa Inhibitors. PNP Inhibitor (BCX-4208), completed a Phase I single dose pharmacokinetic trial, and is intended for the treatment of T-cell mediated autoimmune diseases, including psoriasis. Hepatitis C Polymerase Inhibitor, a product under preclinical stage, is intended for the treatment of viral infections. Peramivir, a product under preclinical stage, is intended for the treatment of strains of influenza, including the avian strain H5N1. Tissue Factor/Factor VIIa, a product under lead optimization stage, is intended for the treatment of acute coronary syndromes and complications associated with cardiovascular procedures. The company has an agreement with Green Cross Corp. for the development and commercialization of potent influenza neuraminidase inhibitor. BioCryst Pharmaceuticals was co-founded by Charles E. Bugg and William M. Spencer, III in 1986. The company is based in Birmingham, Alabama. With 38.08 million shares outstanding and 2.44 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of BCRX. According to quarterly data provided by the SEC, there were still 35,976 shares of BCRX that were failing-to-deliver as of September 28, 2007.
CombiMatrix Corp. (NASDAQ: CBMX | news | PowerRating | PR Charts ) develops and sells proprietary technologies, products, and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology research, defense, and homeland security. Its technologies include a platform to produce customizable, in-situ synthesized, and oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations, and proteins. The company's technology application areas comprise genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences, and nanotechnology. It also offers proprietary molecular synthesis and screening methods for the discovery of new drugs. In addition, CombiMatrix has a technology to produce arrays that utilize bacterial artificial chromosomes, enabling genetic analysis. The company was founded in 1995 and is based in Mukilteo, Washington. With 5.99 million shares outstanding and 144,100 shares declared short as of March 2008, there is no longer a failure to deliver in shares of CBMX.
CDC Corp. (NASDAQ: CHINA | news | PowerRating | PR Charts ) provides enterprise software, online games, mobile services and applications, and Internet and media services. The company's Software segment offers enterprise resource planning, customer relationship management, supply chain management, order management systems, human resources and payroll management, and business intelligence products. Its Business Services segment offers information technology services, eBusiness consulting, and Web development and outsourcing, as well as a marketing database and marketing support service. The company's Mobile Services and Applications segment provides news and mobile applications services targeting the consumer market in China. It offers wireless services, including short message service, interactive voice response, multimedia message service, and wireless application protocol. CDC Corporation's Internet and Media segment focuses on online entertainment and Internet products and services that target users in China and Chinese communities worldwide through its portal network china.com and hongkong.com. This segment also includes Singapore-based travel trade publisher and organizer serving the travel and tourism industry in the Asia Pacific region. CDC Corporation's Games segment engages in the development and operation of online games in the People's Republic of China. It offers massive multiplayer online role playing games and massive multiplayer online games, which are online games that allow thousands of users to interact with one another in a virtual world by assuming ongoing roles or characters with different features. It operates in North America, Europe, the Middle East, Africa, and the Asia Pacific region. The company was founded in 1997. It was formerly known as China Information Infrastructure Limited and changed its name to chinadotcom corporation in 2000. Further, the company changed its name to CDC Corporation in 2005. CDC Corporation is headquartered in Causeway Bay, Hong Kong. With 107.07 million shares outstanding and 2.75 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of CHINA. According to quarterly data provided by the SEC, there were still 87,871 shares of CHINA that were failing-to-deliver as of September 13, 2007.
Chartered Semiconductor Manufacturing Ltd. (NASDAQ: CHRT | news | PowerRating | PR Charts ) provides wafer fabrication services and technologies to semiconductor suppliers and systems companies in North America, Europe, and Asia. It manufactures logic semiconductor wafers primarily for the communication, computer, and consumer markets, as well as makes mixed-signal semiconductor wafers using CMOS and BiCMOS processes. The company also provides stand-alone memory devices, including EPROM, EEPROM, SRAM; and Flash and embedded memory consisting of eSRAM, eEEPROM, and eFLASH memories. In addition, Chartered Semiconductor offers assembly and test services, as well as pre-fabrication services, such as engineering and masks generation services to its customers. It has strategic business and technology alliances with IBM, Infineon, Samsung, Freescale, Toshiba, and STMicroelectronics; Chartered Silicon Partners; and Silicon Manufacturing Partners. The company was founded in 1987 and is based in Singapore, Singapore. Chartered Semiconductor Manufacturing, Ltd. is a subsidiary of Singapore Technologies Semiconductors Pte, Ltd. With 253.96 million shares outstanding and 161,500 shares declared short as of March 2008, there is no longer a failure to deliver in shares of CHRT. According to quarterly data provided by the SEC, there were still 34,036 shares of CHRT that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 1,900,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. ANSW has previously paid a $995.00 data fee to BUYINS.NET. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk, CEO www.buyins.net Tom@buyins.net +1-800-715-9999
CONTACT: Thomas Ronk, CEO, Buyins.net Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
